EUVIMEDOpdag EUVIMED
Crossref

Global, regional, and national burden of blindness and vision loss attributable to high fasting plasma glucose from 1990 to 2019, and forecasts to 2030: A systematic analysis for the Global Burden of Disease Study 2019

Cong Li, Guangyao Hua, Shunming Liu, Honghua Yu, Xiaohong Yang iD, Lei Liu

Diabetes/Metabolism Research and Reviews · 2024

DOI: 10.1002/dmrr.3802 ↗

At a glance

Journal article in Diabetes/Metabolism Research and Reviews, 2024. Written by Cong Li and 5 co-authors. Institution: Department of Ophthalmology, Guangdong Eye Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medica…. Major MEDLINE topics: Global Burden of Disease, Blood Glucose. Cited 7 times so far (Crossref); 35 references. Funded by: Special Fund Project of Technology Achievement Transformation in Life and Health Innovation of the Greater Bay Area, GDPH Supporting Fund for Talent Program, National Natural Science Foundation of China.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Aims

To systematically clarify the spatiotemporal trends, and age‐sex‐specific blindness and vision loss (BVL) burden due to high fasting plasma glucose (HFPG) from 1990 to 2019, and project this burden over the next decade. Materials and Methods We obtained the number and rate of years lived with disability (YLDs) for the BVL burden attributable to HFPG by age, sex, socio‐demographic index (SDI), and location between 1990 and 2019 from the Global Burden of Disease (GBD) 2019 database. The average annual percentage changes (AAPCs) were calculated to assess the temporal trends of HFPG‐attributable BVL burden. The Bayesian age‐period‐cohort model was used to predict the HFPG‐attributable BVL burden.

Results

In 2019, the global number and age‐standardized rate (ASR) for YLDs of BVL attributable to HFPG were 673.13 (95% UI: 159.52 to 1565.34) thousand and 8.44 (95% UI: 2.00 to 19.63) per 100,000 people, respectively. The highest burdens were found in Oceania, South Asia, and Southeast Asia, and the BVL burden due to HFPG was higher in the elderly and lower SDI regions. From 1990 to 2019, the global ASR of HFPG‐attributable BVL gradually increased with AAPC (95% CI) being 0.80 (0.74 to 0.86). In addition, the HFPG‐attributable BVL burden will slightly increase in the future decade.

Conclusions

The HFPG remains the important cause of BVL worldwide, placing a substantial disease burden. From 1990 to 2019, the age‐standardized burden of BVL due to HFPG increased, and will consistently increase in the future decade, particularly in the elderly and in regions with middle SDI or below.

Subjects

MeSH terms (MEDLINE)

Global Burden of DiseaseBlood GlucoseMaleFemaleHumansAgedBayes TheoremGlobal HealthBlindnessFastingQuality-Adjusted Life Years

Author keywords

blindness and vision lossglobal burden of diseasehigh fasting plasma glucoseyears lived with disability

Substances

Blood Glucose

Authors and institutions

  • Department of Ophthalmology, Guangdong Eye Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
  • School of Medicine South China University of Technology, Guangzhou, China.
  • Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
  • Guangdong Provincial Key Laboratory of Artificial Intelligence in Medical Image Analysis and Application, Guangzhou, China.
  • Department of Neurosurgery, Jincheng People's Hospital, Jincheng, Shanxi, China.
  • Department of Ophthalmology, The Third People's Hospital of Dalian, Non-Directly Affiliated Hospital of Dalian Medical University, Dalian, China.

ORCID profiles: Xiaohong Yang

Funding

  • Special Fund Project of Technology Achievement Transformation in Life and Health Innovation of the Greater Bay Area
  • GDPH Supporting Fund for Talent Program
  • National Natural Science Foundation of China
  • Science and Technology Program of Guangzhou
  • Outstanding Young Talent Trainee Program of Guangdong Provincial People's Hospital
  • GDPH Scientific Research Funds for Leading Medical Talents and Distinguished Young Scholars in Guangdong Province
  • Talent Introduction Fund of Guangdong Provincial People's Hospital
  • The launch fund of Guangdong Provincial People's Hospital for NSFC

Cite

APA

Li, C., Hua, G., Liu, S., Yu, H., Yang, X., & Liu, L. (2024). Global, regional, and national burden of blindness and vision loss attributable to high fasting plasma glucose from 1990 to 2019, and forecasts to 2030: A systematic analysis for the Global Burden of Disease Study 2019. Diabetes/Metabolism Research and Reviews. https://doi.org/10.1002/dmrr.3802

Vancouver

Li C, Hua G, Liu S, Yu H, Yang X, Liu L. Global, regional, and national burden of blindness and vision loss attributable to high fasting plasma glucose from 1990 to 2019, and forecasts to 2030: A systematic analysis for the Global Burden of Disease Study 2019. Diabetes/Metabolism Research and Reviews. 2024. doi:10.1002/dmrr.3802

BibTeX
@article{Li2024,
  author = {Li, Cong and Hua, Guangyao and Liu, Shunming and Yu, Honghua and Yang, Xiaohong and Liu, Lei},
  title = {Global, regional, and national burden of blindness and vision loss attributable to high fasting plasma glucose from 1990 to 2019, and forecasts to 2030: A systematic analysis for the Global Burden of Disease Study 2019},
  journal = {Diabetes/Metabolism Research and Reviews},
  year = {2024},
  doi = {10.1002/dmrr.3802}
}
Start for free →